Thermo Fisher Scientific (TMO) offers growth potential with diverse revenue streams, fair valuation, and strong CAGR ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

Lyndra Therapeutics and Thermo Fisher Scientific have entered a strategic partnership to develop Lyndra's long-acting oral ...

Shares of Thermo Fisher Scientific Inc. TMO rose 1.86% to $561.71 Thursday, on what proved to be an all-around rough trading ...

Thermo Fisher Scientific Inc. closed 8.73% below its 52-week high of $627.88, which the company reached on September 10th.

Ameritas Advisory Services LLC reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 19.8% during ...

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $559.65 which represents a decrease of $-2.06 or -0.37% from the prior close of $561.71. The stock opened at $562.46 and ...

Thermo Fisher Scientific TMO +0.14% Get Free Report has outperformed the market over the past 15 years by 6.03% on an ...

As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $551.47 which represents a decrease of $-5.52 or -0.99% from the prior close of $556.99. The stock opened at $557.88 and ...

--(BUSINESS WIRE)-- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the UK ...